{"id":2821,"date":"2017-03-17T13:17:40","date_gmt":"2017-03-17T12:17:40","guid":{"rendered":"http:\/\/wordpress.p545550.webspaceconfig.de\/uncategorized\/im-izb-werden-die-ideen-von-morgen-geboren\/"},"modified":"2020-07-14T12:44:57","modified_gmt":"2020-07-14T10:44:57","slug":"im-izb-werden-die-ideen-von-morgen-geboren","status":"publish","type":"post","link":"https:\/\/www.izb-online.de\/en\/im-izb-werden-die-ideen-von-morgen-geboren\/","title":{"rendered":"The ideas of tomorrow are born at the IZB"},"content":{"rendered":"

[vc_row el_class=”gco-magazine-container”][vc_column el_class=”bildspalte”][vc_row_inner][vc_column_inner offset=”vc_col-lg-12 vc_col-md-12″][vc_column_text el_class=”gco-magazine–title”]<\/p>\n

The ideas of tomorrow are born at the IZB<\/h1>\n

[\/vc_column_text][vc_column_text el_class=”gco-magazine–post-date”]March 2017[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_single_image image=”2805″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 IZB[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription”](f.l.t.r.) Dr. Holger Reitinger, Gesch\u00e4ftsf\u00fchrer \/ CEO, Forbion Capital Partners, Dr. Peter Hanns Zobel, Gesch\u00e4ftsf\u00fchrer \/ CEO, IZB, Bettina Reckter, Journalistin \/ Journalist VDI Nachrichten, Jens Klein, Gesch\u00e4ftsf\u00fchrer \/ CEO, Amsilk GmbH, Dr. Matthias Kromayer, Vorstand \/ Chairman, MIG AG[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine-container–copy”][vc_column_inner][vc_column_text]Network event Biotech Press Lounge in February 2017: Amsilk cooperates with Adidas and presents the first sports shoe with degradable nature-identical silk biopolymers<\/strong><\/p>\n

On February 16, 2017, the Innovation and Start-up Center for Biotechnology (IZB) hosted the fourth Biotech Press Lounge in the Faculty Club G2B (Gateway to Biotech).
\n\u201cThe ideas of tomorrow are born at the IZB,\u201d said Dr. Zobel, CEO of the IZB, when happily welcoming over 100 guests. \u201cI am always pleased when IZB companies make a breakthrough and funding is available for market entry,\u201d said Zobel in his speech.
\nBettina Reckter from VDI News moderated the talks by Dr. Holger Reitinger (CEO of Forbion Capital Partners), Jens Klein (CEO of Amsilk GmbH) and Dr. Matthias Kromayer (Chairman of MIG AG).
\nBoston, USA, is the undisputed number 1 location \u00adfor biotech companies.
\nIn his talk \u201cWhat can we learn from the Americans about financing rounds and what should we rather leave alone?\u201d Holger Reithinger of Forbion Capital Partners shared his experience. \u201cIn Germany, as is so often the case, we think too small. Therefore, we realize only a fraction of the potential,\u201d according to Reithinger. His partnership has invested in Europe and the USA for over 10 years, and currently manages a portfolio of about 30 active companies.[\/vc_column_text][vc_column_text css=”.vc_custom_1583761043671{background-color: #1e73be !important;}” el_class=”redaktionell”][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine–quote gco-magazine–quote-vertical-center”][vc_column_inner][vc_column_text]<\/p>\n

\"Portrait-Jens-Holstein\"
\n\u00a9 IZB
\n<\/span><\/div>\n
\n
\u201eAn excellent communication platform for the industry \u2013 well beyond the boundaries of Martinsried.\u201d<\/h6>\n

Jens Holstein, Chief Financial Officer
\nMorphosys AG<\/p>\n<\/div>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”two-columns” css=”.vc_custom_1591797243971{margin-top: 33px !important;}”][vc_column_inner][vc_single_image image=”2810″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 IZB[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription”]Dr. Peter Hanns Zobel
\nCEO
\nIZB[\/vc_column_text][vc_single_image image=”2812″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 IZB[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription”]Anke Linnartz
\nVice President, Head of Corporate Communications and IR
\nMorphosys AG[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine-container–copy”][vc_column_inner][vc_column_text]\u201eSports shoes made out of natural silk biopolymers, developed together with Adidas, are setting new standards in the field of sustainability and functionality of textiles. Further products, which we are currently developing with well-known international cooperation partners from the industry and textile sector, will follow,\u201d says Jens Klein, CEO of Amsilk. \u201cBasically, the Biosteel\u00ae fiber is suitable for all functional applications in the textile industry. Due to its functional properties and versatile applications in various products and industries, Biosteel\u00ae products have an enormous market potential,\u201d says Klein about the innovative product.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine–quote”][vc_column_inner][vc_column_text]<\/p>\n

\u201eThe tremendous response to the event surprised even me. It is fantastic to have a discussion with known experts from the biotech and start-up scene in front of such a competent audience.\u201d<\/h6>\n

Bettina Reckter, Journalist VDI Nachrichten<\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine-container–copy” css=”.vc_custom_1591797252236{margin-top: 21px !important;}”][vc_column_inner][vc_column_text]In the context of his talk \u201cWhy biotechs sometimes fail and what can one do to prevent it,\u201d Dr. Matthias Kromayer, Chairman of MIG AG, stressed that biotechnology companies\u2019 well-known success factors alone are not enough for success. \u201cFantastic technology, clear medical need, unlimited application opportunities across different sectors, huge markets \u2013 those who focus on these factors, lose track of a crucial component. Much more important is a resilient business model,\u201d according to Kromayer.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”two-columns”][vc_column_inner][vc_single_image image=”2814″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 IZB[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription”]Jens Klein
\nCEO
\nAmsilk GmbH[\/vc_column_text][vc_single_image image=”2816″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 IZB[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription”]Dr. Matthias Kromayer
\nChairman
\nMIG AG[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine–quote” css=”.vc_custom_1594723280729{margin-bottom: 30px !important;}”][vc_column_inner][vc_column_text]<\/p>\n

\u201eThe casual and informal atmosphere with industry multipliers creates an optimal start-up situation for later business operations.\u201d<\/h6>\n

Karin Hofelich, Publishing Director
\nLife Sciences GoingPublic Media AG<\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner]\n\n

\n \n